Published in Genes Dev on December 01, 1991
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol (1995) 5.18
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev (1997) 5.13
Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev (1992) 3.60
Reconstitution of Bacillus subtilis trp attenuation in vitro with TRAP, the trp RNA-binding attenuation protein. Proc Natl Acad Sci U S A (1993) 2.52
In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol (1993) 2.15
Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J (1995) 2.14
A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc Natl Acad Sci U S A (1996) 2.06
Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen. Mol Cell Biol (1993) 1.98
La autoantigen alleviates translational repression by the 5' leader sequence of the human immunodeficiency virus type 1 mRNA. J Virol (1994) 1.87
Characterization of a "kissing" hairpin complex derived from the human immunodeficiency virus genome. Proc Natl Acad Sci U S A (1994) 1.77
Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J (1994) 1.74
The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol Cell Biol (1997) 1.70
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol (1994) 1.70
Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J Virol (1992) 1.69
Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc Natl Acad Sci U S A (1996) 1.68
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiol Rev (1995) 1.63
Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. J Virol (2003) 1.61
Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol Cell Biol (1993) 1.59
In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res (1993) 1.44
The yeast Saccharomyces cerevisiae YDL112w ORF encodes the putative 2'-O-ribose methyltransferase catalyzing the formation of Gm18 in tRNAs. RNA (1999) 1.41
Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc Natl Acad Sci U S A (1996) 1.38
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci U S A (1998) 1.37
Multiple binding sites for cellular proteins in the 3' end of Sindbis alphavirus minus-sense RNA. J Virol (1993) 1.32
Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J Virol (1994) 1.27
Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro. Proc Natl Acad Sci U S A (1993) 1.24
Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J Virol (1993) 1.24
Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc Natl Acad Sci U S A (1995) 1.22
Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J Virol (1994) 1.22
Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II. Proc Natl Acad Sci U S A (1996) 1.20
Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. J Virol (1994) 1.20
The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA. EMBO J (1995) 1.20
Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J (1997) 1.15
Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc Natl Acad Sci U S A (1999) 1.15
Regulation of eukaryotic gene expression by transcriptional attenuation. Mol Biol Cell (1993) 1.15
TRIP: a novel double stranded RNA binding protein which interacts with the leucine rich repeat of flightless I. Nucleic Acids Res (1998) 1.14
Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J (1995) 1.14
Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication. J Virol (1995) 1.13
Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator. Proc Natl Acad Sci U S A (1992) 1.11
Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. J Virol (1996) 1.11
Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. J Virol (1995) 1.08
An adenosine at position 27 in the human immunodeficiency virus type 1 trans-activation response element is not critical for transcriptional or translational activation by Tat. J Virol (1992) 1.01
Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides. J Virol (1994) 1.00
TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. J Virol (1993) 1.00
TAR-independent replication of human immunodeficiency virus type 1 in glial cells. J Virol (1992) 0.98
A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription. Nucleic Acids Res (1996) 0.95
Induction of RNA-binding proteins in mammalian cells by DNA-damaging agents. Proc Natl Acad Sci U S A (1994) 0.94
Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. J Virol (1997) 0.91
Identification of a novel HIV-1 TAR RNA bulge binding protein. Nucleic Acids Res (1994) 0.91
Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator. J Virol (1995) 0.90
Human immunodeficiency virus type 1 Tat-mediated trans activation correlates with the phosphorylation state of a cellular TAR RNA stem-binding factor. J Virol (1992) 0.90
The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription. Proc Natl Acad Sci U S A (1995) 0.90
Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin. Nucleic Acids Res (1997) 0.89
Peptide models of the Tat-TAR protein-RNA interaction. Protein Sci (1992) 0.88
NMR characterization of a kissing complex formed between the TAR RNA element of HIV-1 and a DNA aptamer. Nucleic Acids Res (2000) 0.87
TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation. Nucleic Acids Res (1997) 0.86
Juxtaposition between activation and basic domains of human immunodeficiency virus type 1 Tat is required for optimal interactions between Tat and TAR. J Virol (1993) 0.86
An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy. J Virol (1995) 0.84
The preprotachykinin A promoter interacts with a sequence specific single stranded DNA binding protein. Nucleic Acids Res (1993) 0.82
Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes. J Virol (1995) 0.81
The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation. J Virol (1997) 0.78
A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA. J Virol (1995) 0.78
Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells. Nucleic Acids Res (1997) 0.76
Orientation-specific cis complementation by bulge- and loop-mutated human immunodeficiency virus type 1 TAR RNAs. J Virol (1994) 0.75
Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell (1985) 11.03
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell (1987) 10.22
A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell (1998) 10.14
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science (1986) 8.01
The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev (1998) 4.38
A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev (1991) 4.25
Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vitro. Nature (1985) 3.99
Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A (2001) 3.23
Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A (1995) 2.92
Essential contact residues within SV40 large T antigen binding sites I and II identified by alkylation-interference. Cell (1984) 2.59
Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature (1993) 2.43
In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions. Genes Dev (1989) 2.36
Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev (1997) 2.25
Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner. New Biol (1990) 2.21
In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. EMBO J (1987) 2.09
Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev (2000) 2.07
NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev (1996) 2.07
Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev (1995) 2.07
The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. Genes Dev (1993) 2.04
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest (1999) 2.02
Prediction of femoral fracture load using automated finite element modeling. J Biomech (1998) 1.99
GABAB receptors - the first 7TM heterodimers. Trends Pharmacol Sci (1999) 1.94
Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J Virol (1998) 1.93
CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol Cell Biol (2000) 1.89
HIV-1 Tat: coping with negative elongation factors. Curr Opin Immunol (1999) 1.81
Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc Natl Acad Sci U S A (1996) 1.68
Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev (1997) 1.65
Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. Genes Dev (2001) 1.48
Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem (2000) 1.41
Cloning of an SNF2/SWI2-related protein that binds specifically to the SPH motifs of the SV40 enhancer and to the HIV-1 promoter. J Biol Chem (1995) 1.35
Friction in airway smooth muscle: mechanism, latch, and implications in asthma. J Appl Physiol (1985) (1996) 1.34
Mutational analysis of simian virus 40 large T antigen DNA binding sites. EMBO J (1984) 1.31
Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res (2001) 1.30
HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harb Symp Quant Biol (1998) 1.29
HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. J Biol Chem (2000) 1.26
Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. J Physiol (1994) 1.26
Home monitoring of transcutaneous oxygen tension in the early detection of hypoxaemia in infants and young children. Arch Dis Child (1991) 1.23
Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. J Biol Chem (1998) 1.18
Prediction of fracture location in the proximal femur using finite element models. Med Eng Phys (2001) 1.13
Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover. J Biol Chem (1997) 1.13
HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcription start site. J Biol Chem (1993) 1.13
Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens (1991) 1.10
A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy. Urology (2000) 1.10
Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. Mol Psychiatry (2011) 1.09
31P NMR saturation-transfer measurements in Saccharomyces cerevisiae: characterization of phosphate exchange reactions by iodoacetate and antimycin A inhibition. Biochemistry (1987) 1.05
Regulation of BRCA1. Nature (1995) 1.04
D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol Pharmacol (1996) 0.99
Cell-specific expression of group X and group V secretory phospholipases A(2) in human lung airway epithelial cells. Am J Respir Cell Mol Biol (2000) 0.97
(2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors. J Pharmacol Exp Ther (1997) 0.97
Role of protein kinase C in calcium sensitization during muscarinic stimulation in airway smooth muscle. Am J Physiol (1997) 0.95
Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. Urology (1999) 0.90
Halothane attenuates calcium sensitization in airway smooth muscle by inhibiting G-proteins. Anesthesiology (1998) 0.89
Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro. Neuroscience (1994) 0.88
cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. Am J Physiol (1998) 0.88
Cloning and characterization of the human galanin GALR2 receptor. Peptides (1998) 0.87
Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors. Neuropharmacology (2010) 0.86
Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants. Brain Res Mol Brain Res (1994) 0.86
Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1. Proc Natl Acad Sci U S A (1995) 0.85
Induction of heat shock proteins by canavanine in Tetrahymena. No change in ATP levels measured in vivo by NMR. J Biol Chem (1986) 0.85
Reversibility characteristics of glucose-induced trehalase activation associated with the breaking of dormancy in yeast ascospores. Eur J Biochem (1983) 0.85
In vivo 31P nuclear magnetic resonance saturation transfer measurements of phosphate exchange reactions in the yeast Saccharomyces cerevisiae. FEBS Lett (1985) 0.84
Calcium concentration-dependent mechanisms through which ketamine relaxes canine airway smooth muscle. Anesthesiology (1997) 0.84
Biological actions of oncogenes. Pharmacol Ther (1993) 0.83
Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor. J Med Chem (1996) 0.83
Molecular modelling and site-directed mutagenesis of human GALR1 galanin receptor defines determinants of receptor subtype specificity. Protein Eng (2002) 0.83
The strain variation and virulence of granulovirus of diamondback moth (Plutella xylostella Linnaeus, Lep., Yponomeutidae) isolated in Kenya. J Invertebr Pathol (2002) 0.82
An in situ hybridization study of the distribution of the GABA(B2) protein mRNA in the rat CNS. Brain Res Mol Brain Res (1999) 0.81
Cross-bridge cycling kinetics, actomyosin ATPase activity and myosin heavy chain isoforms in skeletal and smooth respiratory muscles. Comp Biochem Physiol B Biochem Mol Biol (1998) 0.81
Efficacy trials with tissue-culture grown, inactivated vaccines against chlamydial abortion in sheep. Vaccine (1995) 0.81
Effects of intravenous anesthetics on Ca2+ sensitivity in canine tracheal smooth muscle. Anesthesiology (2000) 0.81
Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIA. Tumour Biol (1998) 0.81
The effects of ethanol on CA(2+) sensitivity in airway smooth muscle. Anesth Analg (2001) 0.80
Calcium sensitization produced by G protein activation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2001) 0.80
Protein and RNA affinity selection techniques using HIV-1 Tat. Methods Enzymol (1999) 0.79
The Tecumseh Blood Pressure Study. Normative data on blood pressure self-determination. Arch Intern Med (1990) 0.79
The in vivo production of Spodoptera littoralis nuclear polyhedrosis virus. J Virol Methods (1998) 0.79
A versatile, computer-controlled, closed-loop system for continuous infusion of muscle relaxants. Mayo Clin Proc (1993) 0.78
Effect of halothane on intracellular calcium oscillations in porcine tracheal smooth muscle cells. Am J Physiol (1999) 0.78
The HIP116 SNF2/SW12-related transcription factor gene (SNF2L3) is located on human chromosome 3q25.1-q26.1. Genomics (1995) 0.78
Differential backfilling of interneuron populations based upon axon projections in a lobster abdominal ganglion. J Neurobiol (1983) 0.78
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer. Urology (1996) 0.78
Relationship between force and regulatory myosin light chain phosphorylation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2000) 0.78
Hydrogen peroxide decreases Ca(2+) sensitivity in airway smooth muscle by inhibiting rMLC phosphorylation. Am J Physiol (1999) 0.78
Halothane attenuation of calcium sensitivity in airway smooth muscle. Mechanisms of action during muscarinic receptor stimulation. Anesthesiology (1997) 0.78
Postural interneurons in the abdominal nervous system of lobster. I. Organization, morphologies and motor programs for flexion, extension and inhibition. J Comp Physiol A (1986) 0.78
Technical evaluation of five glucose meters with data management capabilities. Am J Clin Pathol (1999) 0.77
Effect of phorbol esters on Ca2+ sensitivity and myosin light-chain phosphorylation in airway smooth muscle. Am J Physiol (1998) 0.77
Halothane and potassium channels in airway smooth muscle. Br J Anaesth (1996) 0.77
The role of cGMP in the relaxation to nitric oxide donors in airway smooth muscle. Eur J Pharmacol (1998) 0.77
Use of nitric oxide-nucleophile adducts as biological sources of nitric oxide: effects on airway smooth muscle. J Pharmacol Exp Ther (1996) 0.77
Stereospecific effects of ketamine enantiomers on canine tracheal smooth muscle. Br J Pharmacol (1997) 0.76
Antisense Blockade of Expression : SNAP-25 In Vitro and In Vivo. Methods Mol Med (1996) 0.76
Chemicals that footprint DNA: hitting HIV-1 in the minor groove. Proc Natl Acad Sci U S A (1998) 0.76
S-nitrosoglutathione-induced decrease in calcium sensitivity of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2000) 0.76
Taking out Tat. Nat Biotechnol (1996) 0.75
Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons. Neurotoxicology (1986) 0.75
Outreach teachers essential. Br Dent J (2017) 0.75
Infection hazards of patient lifting slings. Nurs Times (1993) 0.75
Drug-specific effects of volatile anesthetics on Ca2+ sensitization in airway smooth muscle. Anesth Analg (1998) 0.75
CK-MB isoforms for early risk stratification of emergency department patients. Clin Chim Acta (2000) 0.75